Market Size and Growth

As per the Cell Cryopreservation Equipment Market size analysis conducted by the CMI team, the cell cryopreservation equipment market is expected to record a CAGR of 12.34% from 2026 to 2035. In 2026, the market size was USD 3.09 Billion. By 2035, the valuation is anticipated to reach USD 8.73 Billion.

Overview

As per the industry experts at CMI, the global cell cryopreservation equipment market will witness a stellar CAGR between 2025 and 2034. This could be attributed to a substantial growth in gene/cell therapies (such as CAR-T), expansion of biobanking, increased infertility treatments (IVF), and extensive research in stem cells, with North America and the Asia Pacific being the torchbearers. Challenges include higher initial costs, which may prohibit the small players from entering the market.

Key Trends & Drivers

  • Demand for Regenerative Medicine & Cell Therapies to Spell Growth: Expansion of clinical and research trials for immunotherapies, personalized medicine, and stem cell treatments needs reliable storage. Delayed parenthood has increased the demand for cryopreservation of eggs, embryos, and sperm, thereby boosting the demand for IVF clinics. Regenerative therapies are dependent on the storage of therapeutic cells (such as stem cells) without damage. As such, cryopreservation equipment is necessary for preserving their function till use in patients.
  • Expansion of Biobanks to Catalyze Growth: Rising adoption of tissue and cell storage enables the expansion of biobanks for clinical and research use. Growing incidences of chronic diseases along with an aging population do fuel the demand for advanced research and therapies. Biobanks store different cell samples for clinical and research use. This does mean increased demand for cell cryopreservation equipment.

Report Scope

Feature of the ReportDetails
Market Size in 2026USD 3.09 Billion
Projected Market Size in 2035USD 8.73 Billion
Market Size in 2025USD 2.75 Billion
CAGR Growth Rate12.34% CAGR
Base Year2025
Forecast Period2026-2035
Key SegmentBy Product, Application, End-use and Region
Report CoverageRevenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional ScopeNorth America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying OptionsRequest tailored purchasing options to fulfil your requirements for research.

SWOT Analysis

  • Strengths: AI, automation, improved cryoprotectants (DMSO), and advanced cryo-freezers improve cell survival. Cell cryopreservation extends support to stem cell research, personalized medicine, and regenerative therapies, thereby boosting the cell cryopreservation equipment market. Also, better techniques and equipment translate into higher success rates regarding stored cells.
  • Weaknesses: Advanced systems call for higher capital investments, which act as a significant barrier. Also, cryopreservation equipment needs skilled personnel for operation as well as maintenance. Furthermore, management of massive biobanks does present logistical challenges.
  • Opportunities: The cryopreservation equipment market is seeing opportunities in the form of the need for preserved, patient-specific biological samples. The Asia-Pacific is offering higher potential for growth. Expansion of cell/gene therapies does create novel niches. Increased investments in R&D activities do fuel expansion of biobanks.
  • Threats: EMA, FDA have their rules for compliance, which creates non-uniformity with respect to adherence. Higher equipment and operational costs do exercise limits on smaller labs. The potential for cell damage (in the form of osmotic shock, ice crystals) can’t be ruled out.

List of the prominent players in the Cell Cryopreservation Equipment Market:

  • Thermo Fisher Scientific Inc.
  • Azenta US Inc.
  • MVE Biological Solutions
  • INOXCVA
  • Haier Biomedical
  • Kirsch GmbH
  • Planer (a Hamilton Thorne company)
  • Eppendorf SE
  • Labtron Equipment Ltd.
  • Others

The Cell Cryopreservation Equipment Market is segmented as follows:

By Product

  • Equipment
    • Freezers
    • Liquid Nitrogen Supply Tanks
    • Incubators
  • Consumables/Accessories
    • Cryogenic Vials
    • Cryogenic Tubes
    • Cooler Boxes/Containers

By Application

  • Stem Cells
  • Reproductive Cells
  • Bioproduction Cell Lines
  • Primary Cells

By End-use

  • Biopharmaceutical & Pharmaceutical Companies
  • Academic and Research Institutes
  • Biobanks
  • IVF Clinics

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America